KPJ Healthcare outlook brightens on private care demand, expansion
KUALA LUMPUR: Research houses remain positive on KPJ Healthcare Bhd’s longer-term prospects, supported by sustained demand for private healthcare, capacity expansion and ongoing efforts to improve operational efficiency.
KUALA LUMPUR: Industry analysts maintain a positive outlook on KPJ Healthcare Bhd, buoyed by ongoing demand for private healthcare services, capacity growth, and initiatives to enhance operational efficiency. PublicInvest Bank Bhd expressed cautious optimism on KPJ's growth trajectory, citing the group's expansion of capacity, asset optimization, and the introduction of MediASAS under healthcare financing reforms as factors that could improve affordability and accessibility to private healthcare.
Despite global economic and geopolitical uncertainties, KPJ's focus on domestic operations provides some level of resilience. However, talent shortages and cost pressures remain significant challenges that could impact margins.
KPJ's Q2 FY26 results, ending June 30, 2026 (Q2 FY26), were in line with expectations, accounting for 46% of its full-year forecast and 44% of consensus estimates. The company's net profit increased 26.7% year-on-year to RM103.9 million, driven by higher patient visits, increased surgeries, and an improved case mix. Excluding non-operating items, core net profit rose 31% YoY to RM110 million.
Both PublicInvest and Hong Leong Investment Bank Bhd (HLIB) maintained their FY26 to FY28 earnings forecasts and reiterated a neutral stance on KPJ, with unchanged target prices of RM3.17 and RM3.79, respectively.
HLIB expects KPJ's 2026 revenue and earnings to grow by 9.3% and 6.1% YoY, respectively, driven by structural tailwinds such as an ageing population, rising prevalence of chronic diseases, increasing preference for private hospitals, and a persistent supply-demand imbalance for hospital beds. The bank anticipates seasonally stronger revenue and earnings for KPJ in the second half, particularly in the fourth quarter, due to a more favourable mix of elective surgeries.
HLIB attributes its earnings upgrades to potential efficiency gains from cost optimization initiatives and the rollout of multiple Centres of Excellence, which could lift revenue per patient and EBITDA margins.
Written by urgent.news from New Straits Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
